
22HLT06
GenomeMET
Metrology for genomic profiling to support early cancer detection and precision medicine
The project 22HLT06 GenomeMET has received funding from the European Partnership on Metrology, co-financed by the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.
The Project
GenomeMET Work Packages
The GenomeMET project is structured into the following 6 Work Packages:
Develop Reference Measurement Systems (RMS) for validating and ensuring the quality assurance (QA) of genomic profiling IVDs.

News Updates

The GenomeMET project has successfully concluded, marking an important step towards strengthening the metrological infrastructure supporting cancer genomic profiling across Europe.
Throughout the project, the GenomeMET consortium worked to improve the accuracy, reliability and comparability of molecular measurements in oncology, contributing to the development of reference measurement procedures, reference materials and quality assurance approaches.
GenomeMET achievements highlighted in EURAMET news
The project's key achievements and their potential impact on cancer genomic diagnostics are highlighted in a recently published EURAMET news article:
Developing metrological infrastructure needed to implement cancer genomic profiling across Europe
Discover how GenomeMET has contributed to advancing reliable genomic measurements in oncology!



















